You have 9 free searches left this month | for more free features.

Condition

Carcinoma, Non-Small-Cell Lung (1)

Colorectal Cancer (1)

Head and Neck Squamous Cell Carcinoma (1)

Malignant Melanoma (1)

Metastatic Pancreatic Ductal Adenocarcinoma (1)

Non Small Cell Lung Cancer (1)

Pancreatic Ductal Adenocarcinoma (1)

Triple Negative Breast Cancer (1)

Urothelial Carcinoma (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Cantargia AB (3)

Collaborator

Intervention

can04 (3)

cisplatin (1)

folfirinox (1)

gemcitabine (1)

nab-paclitaxel (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

can04

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)

Recruiting

Metastatic Pancreatic Ductal Adenocarcinoma

CAN04
FOLFIRINOX

Bordeaux, France
+7 more

May 16, 2022

Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Triple Negative Breast Cancer Trial in Worldwide (CAN04,

Recruiting

Non Small Cell Lung Cancer
+3 more

CAN04
+3 more

Salzburg, Austria
+27 more

Aug 4, 2021

NSCLC, Urothelial Carcinoma, Malignant Melanoma Trial in Aurora, Lake Mary, Philadelphia (CAN04, Pembrolizumab)

Recruiting

Carcinoma, Non-Small-Cell Lung
+3 more

CAN04
Pembrolizumab

Aurora, Colorado
+2 more

Nov 17, 2020